Higher baseline CHG, greater cumulative cuCHG, and persistently elevated CHG trajectories were independently associated with increased incident CVD, and findings were robust in subgroup and sensitivity analyses.
Abstract
The cholesterol–HDL–glucose (CHG) index reflects metabolic stress related to insulin resistance. Evidence on whether baseline CHG, cumulative CHG (cuCHG), and long-term CHG trajectories predict incident cardiovascular disease (CVD) is limited. We investigated these associations in Chinese adults aged ≥45 years.
We analyzed 4,213 participants in the China Health and Retirement Longitudinal Study (2011–2020). Baseline CHG, cuCHG, and CHG trajectories (derived using K-means clustering) represented static, cumulative, and dynamic metabolic exposure. Incident CVD was physician-diagnosed. Cox models with restricted cubic splines estimated hazard ratios (HRs) and exposure–response relationships.
Over 8.18 ± 1.56 years of follow-up, 938 participants developed CVD. Each one-unit increase in baseline CHG and cuCHG was associated with 38% and 13% higher CVD risk, respectively (HR = 1.38, 95% CI 1.17–1.62; HR = 1.13, 95% CI 1.06–1.21; both p < 0.001). CVD risk increased across CHG and cuCHG quartiles, with linear dose–response patterns. A persistently high CHG trajectory conferred the greatest CVD risk (HR = 1.46, 95% CI 1.12–1.90), and findings were robust in subgroup and sensitivity analyses.
Higher baseline CHG, greater cumulative cuCHG, and persistently elevated CHG trajectories were independently associated with increased incident CVD. Sustained metabolic stress reflected by long-term CHG elevation may have cumulative adverse cardiovascular effects. CHG-based dynamic indicators provide simple and clinically relevant measures for early CVD risk detection and prevention.Graphical AbstractRCS curves
Background Insulin resistance and central adiposity are key drivers of cardiovascular disease (CVD). Although the CHG index and obesity‐related indicators can separately predict metabolic risks, this study explored the predictive value of their composite indices and longitudinal trajectories for incident CVD. Methods B...
Lin-Ying Xia, T. Ji, Y. Wang et al.· Cardiovascular Therapeutics· 0 citations
Repeated TyG-CVAI assessment may provide complementary information on longitudinal metabolic-adiposity burden, although its incremental discriminatory value was modest and requires external validation before clinical application.
Z. Sha, Y. Qiao, G. Yan et al.· BMC Cardiovascular Disorders· 0 citations
AIM
To examine associations of cumulative triglyceride-glucose index (TyG) and obesity-related derivatives, and their two-point change patterns, with incident cardiovascular disease (CVD) among middle-aged and older adults with low handgrip strength.
METHODS
This study included 607 China Health and Retirement Longitu...
Yu-Qing Du, Wei-Xian Wang, Xin Ding et al.· Geriatrics & Gerontology Int...· 0 citations
Findings underscore the partial mediating role of metabolic comorbidities in the TyG index-CVD association and suggest future research should explore residual pathways to fully elucidate this association.
BACKGROUND AND AIMS
The cholesterol, high-density lipoprotein cholesterol, and glucose (CHG) has been proposed as a composite metabolic index that may reflect disturbances in glucose and lipid metabolism associated with insulin resistance. We aimed to systematically evaluate the individual and joint associations of lon...
Wen-Qi Xu, Xiao-Rong Li, S. Chen et al.· NMCD. Nutrition Metabolism a...· 0 citations